Sudden-onset asthma exacerbations: Clinical features, response to therapy, and 2-week follow-up

European Respiratory Journal

Volumn 15, Issue 2, 2000, Pages 266-273

  Barr, R G ^a   Woodruff, P G ^a,b,c   Clark, S ^a   Camargo Jr , C A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asthma exacerbation; Sudden onset; Triggers

Indexed keywords

ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; SALMETEROL; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CLINICAL EXAMINATION; DISEASE SEVERITY; EXERCISE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RESPIRATORY TRACT INFECTION; SOCIAL PROBLEM; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; COHORT STUDIES; EMERGENCIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033950070     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15b08.x     Document Type: Article

References (36)

1. Picado C. Classification of severe asthma exacerbations: a proposal. Eur Respir J 1996; 9: 1775-1778.
2. Ferrer A, Torre A, Roca J, Sunyer J, Antó JM, Rodriguez-Roisin R. Characteristics of patients with soybean dust induced acute severe asthma requiring mechanical ventilation. Am Rev Respir Dis 1990; 142: 429-433.
3. Wasserfallen JB, Schaller MD, Feihl F, Perret CH. Sudden asphyxie asthma: a distinct entity? Am Rev Respir Dis 1990; 142: 108-111.
4. Woodruff PG, Emond SD, Singh AK, Camargo CA Jr. Sudden-onset severe acute asthma: clinical features and response to therapy. Acad Emerg Med 1998; 5: 695-701.
5. Kallenbach JM, Frankel AH, Lapinsky SE, et al. Determinants of near fatality in acute severe asthma. Am J Med 1993; 95: 265-272.
6. Molfino NA, Nannini LJ, Martelli AN, Slutsky AS. Respiratory arrest in near-fatal asthma. N Engl J Med 1991; 324: 285-288.
7. Robertson CF, Rubinfeld AR, Bowes G. Deaths from asthma in Victoria: a 12-month survey. Med J Aust 1990; 152:511-517.
8. Saetta M, Thiene G, Crescioli S, Fabbri LM. Fatal asthma in a young patient with severe bronchial hyperresponsiveness but stable peak flow records. Eur Respir J 1989; 2: 1008-1012.
9. Robin ED, Lewiston N. Unexpected, unexplained sudden death in young asthmatic subjects. Chest 1989; 96: 790-793.
10. Jenkins PF, Benfield GFA, Smith AP. Predicting recovery from acute severe asthma. Thorax 1981; 36: 835-841.
11. Camargo CA Jr., Woodruff PG. Management of acute asthma in US emergency departments: the Multicenter Asthma Research Collaboration. Am J Respir Crit Care Med 1998; 157: A623.
12. Anonymous. National Asthma Education and Prevention Program. Expert Panel Report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD, USA, National Institutes of Health, 1997.
13. Anonymous. The Sourcebook of Zip code demographics. 12th Edn. Fairfax, VA, USA, CACI Marketing Systems, 1997.
14. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187.
15. Arnold AG, Lane DJ, Zapata E. The speed of onset and severity of acute severe asthma. Br J Dis Chest 1982; 76: 157-163.
16. Sears M, Rea H, Beaglehole R, Gilles A, Holst P, O'Donnell T. Asthma mortality in New Zealand: a two year national study. NZ Med J 1985; 98: 271-275.
17. Antó JM, Sunyer J, Rodriguez-Roisin R, Suarez-Cervera M, Vasquez L, and the Toxicoepidemiology Committee. Community outbreaks of asthma associated with inhalation of soybean dust. N Engl J Med 1989; 320: 1097-1102.
18. Sunyer J, Antó JM, Jose-Rodrigo MJ, Morell F, and the Clinical and Toxicoepidemiology Committee. Case-control study of serum immunoglobulin-E antibodies reactive with soybean epidemic asthma. Lancet 1989; i: 179-182.
19. Codina R, Lockey RF, Fernandez-Caldas E, Rama R. Purification and characterization of a soybean hull allergen responsible for the Barcelona asthma outbreaks. II. Purification and sequencing of the Gly m 2 allergen. Clin Exp Allergy 1997; 27: 424-430.
20. Codina RM, Calderon E, Lockey RF, Fernandez-Caldas E, Rama R. Specific immunoglobulins to soybean hull allergens in soybean asthma. Chest 1997; 111: 75-80.
21. Sabrià J, Antó JM, Sunyer J, et al. Clinical and functional characteristics of patients two years after being affected by the soybean asthma epidemic in Barcelona. Thorax 1994; 49: 906-909.
22. O'Hollaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991; 324: 359-363.
23. Pang X, Alexacos N, Letoumeau R, et al. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process. J Pharmacol Exp Ther 1998; 287: 307-314.
24. Lehrer PM, Hochron S, Carr R, et al. Behavioral task-induced bronchodilation in asthma during active and passive tasks: a possible cholinergic link to psychologically induced airway changes. Psychosom Med 1996; 58: 413-422.
25. Randolph C. Exercise-induced asthma: update on pathophysiology, clinical diagnosis, and treatment. Curr Probl Pediatr 1997; 27: 53-77.
26. Picado C, Castillo JA, Montserrat JM, Agusti-Vidal A. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J 1989; 2: 127-129.
27. Benfield G, Smith A. Predicting rapid and slow response to treatment in acute severe asthma. Br J Dis Chest 1983; 77: 249-254.
28. Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa. Am Rev Respir Dis 1993; 148: 713-719.
29. Carroll N, Carello S, Cooke C, James A. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 1996; 9: 709-715.
30. Faul JL, Tormey VJ, Leonard C, et al. Lung immunopathology in cases of sudden asthma death. Eur Respir J 1997; 10: 301-307.
31. Garrett JE, Lanes SF, Kolbe J, Rea HH. Risk of severe life threatening asthma and β agonist type: an example of confounding by severity. Thorax 1996; 51: 1093-1099.
32. Lanes SF, Lanza LL, Wentworth CE III. Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients of salmeterol. Am J Respir Crit Care Med 1998; 158: 857-861.
33. Williams C, Crossland L, Finnerty J, et al. Case-control study of salmeterol and near-fatal attacks of asthma. Thorax 1998; 53: 7-13.
34. Rea HH, Garrett JE, Lanes SF, Birmann BM, Kolbe J. The association between asthma drugs and severe life-threatening attacks. Chest 1996; 110: 1446-1451.
35. Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993; 306: 1034-1037.
36. Meier CR, Jick H. Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK. Thorax 1997; 52: 612-617.